Navigation Links
Genoptix Announces Filing of Registration Statement for Secondary Public Offering of Common Stock
Date:2/14/2008

CARLSBAD, Calif., Feb. 14 /PRNewswire-FirstCall/ -- Genoptix, Inc. (Nasdaq: GXDX), announced today that it has filed a registration statement with the Securities and Exchange Commission for a proposed secondary public offering of 4,200,000 shares of common stock. The shares of common stock to be registered are currently owned and will be offered and sold by certain existing stockholders, who will receive all of the net proceeds from this offering. Genoptix, Inc. will not be selling any shares of its common stock and will not receive any proceeds from the sale of the shares of common stock being registered. There can be no assurance as to whether or when any such offering would commence or be completed, or as to the actual size or terms of any such offering.

The offering is being made through an underwriting syndicate led by Lehman Brothers Inc. acting as sole book-running manager. Banc of America Securities LLC and UBS Investment Bank are acting as joint lead managers with Cowen and Company, LLC as co-manager. The underwriters have a 30-day option to purchase up to 630,000 additional shares of common stock from these existing stockholders.

A registration statement relating to these securities has been filed with the Securities and Exchange Commission but has not yet become effective. These securities may not be sold nor may offers to buy be accepted prior to the time the registration statement becomes effective. This offering is being made by the existing stockholders solely by means of written prospectus. Copies of the preliminary prospectus relating to the offering may be obtained, when available, by contacting Lehman Brothers Inc., c/o Broadridge Integrated Distribution Services, 1155 Long Island Avenue, Edgewood, NY 11717, (fax): 631-254-7140, or e-mail qiana.smith@broadridge.com, or at the Securities and Exchange Commission's website at http://www.sec.gov.

This press release shall not constitute an offer to sell or a solicitation of an offer to buy, nor shall there be any sale of these securities in any state or jurisdiction in which such an offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such state or jurisdiction.

About Genoptix, Inc.

Genoptix is a specialized laboratory service provider focused on delivering personalized and comprehensive diagnostic services to community- based hematologists and oncologists. Genoptix is headquartered in Carlsbad, California.

Forward-Looking Statements

This press release contains forward-looking statements that are subject to risks and uncertainties that could cause actual results to differ materially from those set forth in the forward-looking statements. Actual results may differ materially from those projected. Genoptix disclaims, however, any intent or obligations to update these forward-looking statements.


'/>"/>
SOURCE Genoptix, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. Genoptix, Inc. Announces Pricing for Initial Public Offering
2. Genoptix, Inc. to Announce Fourth Quarter and Full Year 2007 Financial Results on February 12, 2008
3. Genoptix Reports Strong Financial Results for the Fourth Quarter and Full Year 2007
4. HHS Announces $75 Million in Supplemental Funding to States for Pandemic Flu Preparedness
5. CRC Health Group Announces Acquisition of Bayside Marin Recovery Center, San Rafael
6. UHW Announces: Antelope Valley Hospital Caregivers and Board Vote to Ratify First Union Contract With SEIU UHW-West
7. HEI, Inc. Announces Sale of RFID Division Assets
8. Caraco Pharmaceutical Laboratories, Ltd. Announces FDA Approval to Market Generic Version of Zyloprim(R)
9. Mettler-Toledo International Inc. Announces Webcast of Presentation at Thomas Weisel Partners 2007 Healthcare Conference
10. Z Trim Announces Revocation of Gregory Halpern Severence Agreement
11. Brooke Franchise Corporation Announces Selected July Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/8/2016)... ... December 08, 2016 , ... Catalent Pharma Solutions, the ... and consumer health products, today announced that it had joined the Pharmaceutical Supply ... non-profit organization to unite pharmaceutical and healthcare companies that share a vision of ...
(Date:12/8/2016)... ... December 08, 2016 , ... Today’s patients are ... this in mind, SIGVARIS has created a new line of anti-embolism stockings to ... and provide the benefits of graduated compression when transitioning from recovery to early ...
(Date:12/8/2016)... ... 2016 , ... The Dianne Michael Insurance Agency, an Ohio-based ... is embarking on a charity drive with the aim of generating support for ... or neglected senior dogs in the Cincinnati region, and LuvFurMutts volunteers also work ...
(Date:12/8/2016)... ... December 08, 2016 , ... The Compretta Insurance Agency, a family owned ... and around the Hancock County area, is announcing the launch of a charity effort ... The Hancock County Food Pantry has worked for more than 30 years to meet ...
(Date:12/7/2016)... ... 2016 , ... Students attending Envision’s summer 2017 National ... hands-on experience in an emergency medical simulation, When Care is Hours Away. This ... medical skills that are critical success in a future career and beyond. , ...
Breaking Medicine News(10 mins):
(Date:12/8/2016)... , Dec. 8, 2016  A new study ... that the use of opioid therapy to treat chronic ... the likelihood of more harmful consequences, including death. ... M.D., and Zankhana Mehta , M.D., authored the ... on chronic opioid therapy. The study was published in ...
(Date:12/8/2016)... Inc . hat die behördliche Zulassung durch die CFDA sowie die Produkteinführung ... China angekündigt. ... ... Live Stretta procedure performed and broadcast during the Chinese Congress of Digestive ... , ...
(Date:12/8/2016)... -- According to the research report, the opportunity ... expected to be worth US$9.7 bn by the end of ... forecast years of 2016 and 2024, the global market is ... players operating in the global diabetes injection pens market are ... Ltd., and Sanofi S.A. Transparency Market Research reports that the ...
Breaking Medicine Technology: